Ying Ding

2.0k total citations
76 papers, 863 citations indexed

About

Ying Ding is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ying Ding has authored 76 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 20 papers in Pulmonary and Respiratory Medicine and 19 papers in Surgery. Recurrent topics in Ying Ding's work include RNA modifications and cancer (5 papers), Pancreatic function and diabetes (5 papers) and Renal cell carcinoma treatment (4 papers). Ying Ding is often cited by papers focused on RNA modifications and cancer (5 papers), Pancreatic function and diabetes (5 papers) and Renal cell carcinoma treatment (4 papers). Ying Ding collaborates with scholars based in China, United States and Singapore. Ying Ding's co-authors include Dongming Su, Xiubin Liang, Wei Ren, Yachen Shen, Aimei Li, Wei De, Weiping Jia, Xiufeng Cao, Zhili Liu and Jing Zhou and has published in prestigious journals such as PLoS ONE, Cancer Research and Scientific Reports.

In The Last Decade

Ying Ding

66 papers receiving 853 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Ding China 16 369 238 126 114 109 76 863
Adelheid Kratzer United States 17 302 0.8× 120 0.5× 129 1.0× 70 0.6× 176 1.6× 26 753
Chang Pan China 18 450 1.2× 161 0.7× 107 0.8× 93 0.8× 136 1.2× 45 869
Patrice Maboudou France 16 331 0.9× 117 0.5× 129 1.0× 87 0.8× 86 0.8× 53 950
Chunlai Zeng China 20 413 1.1× 106 0.4× 166 1.3× 136 1.2× 134 1.2× 48 1.1k
Yi Song China 19 456 1.2× 170 0.7× 231 1.8× 147 1.3× 191 1.8× 88 1.1k
Xiaojie He China 17 331 0.9× 150 0.6× 82 0.7× 68 0.6× 66 0.6× 77 927
Guijun Qin China 19 527 1.4× 276 1.2× 79 0.6× 107 0.9× 83 0.8× 49 936
Bin Liang China 15 416 1.1× 387 1.6× 175 1.4× 170 1.5× 244 2.2× 40 1.1k

Countries citing papers authored by Ying Ding

Since Specialization
Citations

This map shows the geographic impact of Ying Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Ding more than expected).

Fields of papers citing papers by Ying Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Ding. The network helps show where Ying Ding may publish in the future.

Co-authorship network of co-authors of Ying Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Ding. A scholar is included among the top collaborators of Ying Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Ding. Ying Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhou, Xin, Chen Wang, Wei Cai, et al.. (2024). Isthmin-1 promotes growth and progression of colorectal cancer through the interaction with EGFR and YBX-1. Cancer Letters. 590. 216868–216868. 3 indexed citations
3.
Liu, Huan, et al.. (2024). Application of Kirschner wire placement guided technology in paediatric supracondylar humerus fractures. BMC Musculoskeletal Disorders. 25(1). 56–56.
4.
Li, Kai, Haoran Sun, Yuxuan Wu, et al.. (2023). The heparan sulfate mimetic Muparfostat aggravates steatohepatitis in obese mice due to its binding affinity to lipoprotein lipase. British Journal of Pharmacology. 180(14). 1803–1818. 4 indexed citations
5.
Wang, Jing, et al.. (2023). Effect of azilsartan on myocardial remodeling after acute myocardial infarction. European Journal of Clinical Pharmacology. 80(2). 223–230.
7.
Ding, Ying, Sha Zhao, Mingna Li, et al.. (2022). The genetic landscape of pancreatic head ductal adenocarcinoma in China and prognosis stratification. BMC Cancer. 22(1). 186–186. 13 indexed citations
8.
Tam, Vincent H., Lawrence Lee, Tat Ming Ng, et al.. (2020). Performance of Population Pharmacokinetic Models in Predicting Polymyxin B Exposures. Microorganisms. 8(11). 1814–1814. 6 indexed citations
9.
Zhang, Fan, Ni Wu, Ranran Jia, et al.. (2020). In silico prediction of bioequivalence of Isosorbide Mononitrate tablets with different dissolution profiles using PBPK modeling and simulation. European Journal of Pharmaceutical Sciences. 157. 105618–105618. 15 indexed citations
10.
Zhao, Lili, Yingtong Chen, Xiaoyang Huang, et al.. (2019). Label‐free multiphoton microscopic imaging as a novel real‐time approach for discriminating colorectal lesions: A preliminary study. Journal of Gastroenterology and Hepatology. 34(12). 2144–2151. 11 indexed citations
11.
Zhao, Lili, Xiaoyang Huang, Ying Ding, et al.. (2018). Label-free imaging for T staging of gastric carcinoma by multiphoton microscopy. Lasers in Medical Science. 33(4). 871–882. 11 indexed citations
12.
Wang, Yiqiu, Ying Ding, Chao Qin, et al.. (2018). Expression of vitamin D receptor in clear cell papillary renal cell carcinoma. Annals of Diagnostic Pathology. 36. 1–4. 1 indexed citations
13.
Ding, Ying, Cong Wang, Xuejie Li, et al.. (2018). Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases. Diagnostic Pathology. 13(1). 54–54. 14 indexed citations
14.
Ren, Wei, Feng Jiang, Jun Lü, et al.. (2014). CCAAT/Enhancer-Binding ProteinαIs a Crucial Regulator of Human Fat Mass and Obesity Associated Gene Transcription and Expression. BioMed Research International. 2014. 1–7. 22 indexed citations
15.
Ding, Ying, et al.. (2014). Luteolin prevents uric acid-induced pancreatic b-cell dysfunction. Journal of Biomedical Research. 28(4). 292–292. 33 indexed citations
16.
Ding, Ying, et al.. (2014). Dezocine pretreatment prevents myoclonus induced by etomidate: a randomized, double-blinded controlled trial. Journal of Anesthesia. 29(1). 143–145. 19 indexed citations
17.
Li, Wei, et al.. (2014). Association of interleukin-4 genetic polymorphisms with sporadic Alzheimer's disease in Chinese Han population. Neuroscience Letters. 563. 17–21. 15 indexed citations
18.
Lü, Jia, Jing Xing, Ying Ding, et al.. (2013). Hyperuricemia Causes Pancreatic β-Cell Death and Dysfunction through NF-κB Signaling Pathway. PLoS ONE. 8(10). e78284–e78284. 76 indexed citations
19.
Sun, Ming, Xiang-hua Liu, Zhili Liu, et al.. (2012). MiR-196a Is Upregulated in Gastric Cancer and Promotes Cell Proliferation by Downregulating p27kip1. Molecular Cancer Therapeutics. 11(4). 842–852. 105 indexed citations
20.
Guo, Yuanyuan, et al.. (2011). Streptozotocin-induced expression of Ngn3 and Pax4 in neonatal rat pancreatic α-cells.. PubMed. 17(23). 2812–20. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026